Royal Philips, a global leader in health technology, has raised €500m (US$539m) in fixed rate notes due 2031 under its EMTN programme. The company has a BBB+ rating by Standard & Poor’s, a Baa1 rating by Moody’s and a BBB+ rating by Fitch. Notes will have a debt-neutral effect, with net proceeds to be used…
Home Healthcare Markets International Business The Netherlands: Royal Philips taps bond markets for €500m